American Shared Hospital Services AMS

Q2 FY2026 · ended Jun 30, 2026 · Revenue $8.43M, +19.2% YoY · Filed Aug 13, 2026

American Shared Hospital Services (AMS) files with the SEC under industry code 8071, Services-Medical Laboratories. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $8.4 million and a net loss of $514,000. Free cash flow was $2.2 million. As of Jun 30, 2026 it held $6.5 million in cash and investments and $20.5 million in total debt.

Revenue
$8.43M
+19.2% vs year-ago quarter
Net income
$-514,000
-83.6% vs year-ago quarter
Operating cash flow
$2.24M
+701.1% vs year-ago quarter
Free cash flow
$2.18M
+195.8% vs year-ago quarter
EPS
$-0.07
-75.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
6.65M
+2.2% vs year-ago quarter
Net cash
$-14.01M
Q2 FY2026
Operating margin
-11.8%
TTM

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
AMS (NYSE)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
744825

Other Services-Medical Laboratories companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$8.4M
$7.1M
$7.7M
$7.2M
$7.1M
Operating income
-$910,000
-$924,000
-$1.4M
-$344,000
-$544,000
Net income
-$514,000
-$612,000
-$631,000
-$17,000
-$280,000
Diluted EPS
-$0.07
-$0.09
-$0.09
$0.00
-$0.04
Operating cash flow
$2.2M
$2.1M
-$704,000
$1.7M
-$372,000
Free cash flow
$2.2M
$2.1M
-$2.7M
-$2.0M
-$2.3M
Total assets
$52.5M
$54.7M
$55.5M
$59.6M
$63.5M
Total liabilities
$26.7M
$28.0M
$27.8M
$31.0M
$34.6M
Stockholders' equity
$23.1M
$23.5M
$24.0M
$24.6M
$24.5M
Cash and investments
$6.5M
$5.0M
$3.5M
$5.1M
$11.1M
Total debt
$20.5M
$21.2M
$21.8M
$22.6M
$22.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Jul 28, 2026 Jul 22, 2026
8-K Current report
Officer or director change
Jul 13, 2026 Jul 7, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 30, 2026 Jun 24, 2026
8-K Current report Jun 4, 2026 May 29, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.